Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes

Thomas Kocher; Patricia Peking; Alfred Klausegger; Eva Maria Murauer; JP Hofbauer; Verena Wally; Thomas Lettner; Stefan Hainzl; Michael Ablinger; Johann Bauer; Julia Reichelt; Ulrich Koller

Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes

Thomas Kocher
, Patricia Peking
, Alfred Klausegger
, Eva Maria Murauer
, JP Hofbauer
, Verena Wally
, Thomas Lettner
, Stefan Hainzl
, Michael Ablinger
, Johann Bauer
, Julia Reichelt
, Ulrich Koller

Forschungsprogramm für Molekulare Therapie bei Genodermatosen
Universitätsklinik für Dermatologie und Allergologie
Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	A57-A57
Fachzeitschrift	HUMAN GENE THERAPY
Jahrgang	28
Ausgabenummer	12
Publikationsstatus	Veröffentlicht - 2017
Veranstaltung	European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress - Berlin, GERMANY Dauer: 1 Jan. 2017 → …

Dieses zitieren

Kocher, T., Peking, P., Klausegger, A., Murauer, E. M., Hofbauer, JP., Wally, V., Lettner, T., Hainzl, S., Ablinger, M., Bauer, J., Reichelt, J., & Koller, U. (2017). Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes. HUMAN GENE THERAPY , 28(12), A57-A57.

Kocher, Thomas ; Peking, Patricia ; Klausegger, Alfred et al. / Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes. in: HUMAN GENE THERAPY 2017 ; Jahrgang 28, Nr. 12. S. A57-A57.

@article{32a3b3012261479d9ab95b018730bafa,

title = "Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes",

author = "Thomas Kocher and Patricia Peking and Alfred Klausegger and Murauer, \{Eva Maria\} and JP Hofbauer and Verena Wally and Thomas Lettner and Stefan Hainzl and Michael Ablinger and Johann Bauer and Julia Reichelt and Ulrich Koller",

year = "2017",

language = "English",

volume = "28",

pages = "A57--A57",

journal = "HUMAN GENE THERAPY ",

issn = "1043-0342",

publisher = "Mary Ann Liebert, Inc. ",

number = "12",

note = "European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress ; Conference date: 01-01-2017",

}

Kocher, T , Peking, P , Klausegger, A, Murauer, EM, Hofbauer, JP, Wally, V, Lettner, T, Hainzl, S , Ablinger, M , Bauer, J, Reichelt, J & Koller, U 2017, 'Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes', HUMAN GENE THERAPY , Jg. 28, Nr. 12, S. A57-A57.

Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes. / Kocher, Thomas ; Peking, Patricia ; Klausegger, Alfred et al.
in: HUMAN GENE THERAPY , Jahrgang 28, Nr. 12, 2017, S. A57-A57.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes

AU - Kocher, Thomas

AU - Peking, Patricia

AU - Klausegger, Alfred

AU - Murauer, Eva Maria

AU - Hofbauer, JP

AU - Wally, Verena

AU - Lettner, Thomas

AU - Hainzl, Stefan

AU - Ablinger, Michael

AU - Bauer, Johann

AU - Reichelt, Julia

AU - Koller, Ulrich

PY - 2017

Y1 - 2017

M3 - Abstract (Journal)

SN - 1043-0342

VL - 28

SP - A57-A57

JO - HUMAN GENE THERAPY

JF - HUMAN GENE THERAPY

IS - 12

T2 - European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress

Y2 - 1 January 2017

ER -

Kocher T , Peking P , Klausegger A, Murauer EM, Hofbauer JP, Wally V et al. Highly efficient and safe CRISPR/Cas9n double nicking-mediated KRT14 repair in epidermolysis bullosa simplex keratinocytes. HUMAN GENE THERAPY . 2017;28(12):A57-A57.